[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE3887417D1 - Thienocinnolinverbindungen und deren verwendung als heilmittel. - Google Patents

Thienocinnolinverbindungen und deren verwendung als heilmittel.

Info

Publication number
DE3887417D1
DE3887417D1 DE88902569T DE3887417T DE3887417D1 DE 3887417 D1 DE3887417 D1 DE 3887417D1 DE 88902569 T DE88902569 T DE 88902569T DE 3887417 T DE3887417 T DE 3887417T DE 3887417 D1 DE3887417 D1 DE 3887417D1
Authority
DE
Germany
Prior art keywords
thienocinnoline
medicine
compounds
thienocinnoline compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE88902569T
Other languages
English (en)
Other versions
DE3887417T2 (de
Inventor
Toru Nakao
Kenji Morita
Masao Hisadome
Shuzo Takehara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Welfide Corp
Original Assignee
Welfide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Welfide Corp filed Critical Welfide Corp
Publication of DE3887417D1 publication Critical patent/DE3887417D1/de
Application granted granted Critical
Publication of DE3887417T2 publication Critical patent/DE3887417T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE3887417T 1987-03-25 1988-03-17 Thienocinnolinverbindungen und deren verwendung als heilmittel. Expired - Fee Related DE3887417T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7083887 1987-03-25
PCT/JP1988/000290 WO1988007533A1 (en) 1987-03-25 1988-03-17 Thienocinnoline compounds and their medicinal application

Publications (2)

Publication Number Publication Date
DE3887417D1 true DE3887417D1 (de) 1994-03-10
DE3887417T2 DE3887417T2 (de) 1994-05-26

Family

ID=13443104

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3887417T Expired - Fee Related DE3887417T2 (de) 1987-03-25 1988-03-17 Thienocinnolinverbindungen und deren verwendung als heilmittel.

Country Status (4)

Country Link
US (1) US4965264A (de)
EP (1) EP0308515B1 (de)
DE (1) DE3887417T2 (de)
WO (1) WO1988007533A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE79540T1 (de) * 1988-02-09 1992-09-15 Ici America Inc Pharmazeutische zusammensetzung.
KR920007437B1 (ko) * 1988-09-21 1992-09-01 요시토미 세이야쿠 가부시기가이샤 티에노시클로 헵타 피리다진 화합물과 그것의 의약용도
CA2028496A1 (en) * 1989-10-31 1991-05-01 Tohru Nakao Thiophene compounds and their pharmaceutical uses
CA2116448A1 (en) * 1991-08-27 1993-03-04 Tohru Nakao Fused pyridazine compound and pharmaceutical use thereof
US5597918A (en) * 1991-08-27 1997-01-28 Yoshitomi Pharmaceutical Industries, Ltd. Fused pyridazine compound
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5745754A (en) * 1980-09-01 1982-03-15 Fujitsu Ltd Clock pickup circuit for dmi code train
JPS6028171B2 (ja) * 1980-09-02 1985-07-03 富士通株式会社 Ｒｏｍを用いた符号復号回路
US4701453A (en) * 1984-02-02 1987-10-20 Warner-Lambert Company Substituted indeno-pyridazinones
JPH06763B2 (ja) * 1984-08-28 1994-01-05 吉富製薬株式会社 ベンゾ〔ｈ〕シンノリン誘導体
JPH0633277B2 (ja) * 1986-01-10 1994-05-02 吉富製薬株式会社 ベンゾチオピラノ〔４，３−ｃ〕ピリダジン化合物
ES2038708T3 (es) * 1987-03-02 1996-07-16 Yoshitomi Pharmaceutical Metodo para producir compuestos de benzotiepino(5,4-c)piridazina.
JP2615785B2 (ja) * 1987-03-25 1997-06-04 吉富製薬株式会社 チエノシンノリン化合物
JPH06156169A (ja) * 1992-11-18 1994-06-03 Mitsubishi Motors Corp キャブオーバトラックのフロントグリル

Also Published As

Publication number Publication date
EP0308515A1 (de) 1989-03-29
US4965264A (en) 1990-10-23
EP0308515B1 (de) 1994-01-26
EP0308515A4 (en) 1990-09-05
DE3887417T2 (de) 1994-05-26
WO1988007533A1 (en) 1988-10-06

Similar Documents

Publication Publication Date Title
DE58904478D1 (de) Strahlungsempfindliche gemische und deren verwendung.
DE3785312D1 (de) Substituierte tetrahydropyridinoxime und ihre verwendung als cholinergische heilmittel.
DE3786205D1 (de) Titanocene und deren verwendung.
DE3677206D1 (de) D-luciferin-derivate und deren verwendung.
FI892225A (fi) Biologiset anturit
DE68905946D1 (de) Sulfoniumsalze und deren verwendung als photoinitiatoren.
DE3783437D1 (de) Heilmittel.
DE3871751D1 (de) Gelbildende organosiloxanzusammensetzungen und deren verwendung.
DE3784199D1 (de) Titanocene und deren verwendung.
DE68920797D1 (de) Herzmittel.
DE3879811D1 (de) Pharmazeutische zusammensetzung und ihre verwendung.
DE58902290D1 (de) Sauerstoffabsorptionsmittel und verwendung desselben.
FI884048A (fi) Foerfarande foer bestaemning av halten av en gaskomponent i en patients andningsluft.
DE3887417D1 (de) Thienocinnolinverbindungen und deren verwendung als heilmittel.
DE3688864D1 (de) L-phenylalanindehydrogenase und deren verwendung.
DE3884742D1 (de) Fluoreszierende Verbindungen und deren Verwendung.
DE3876846D1 (de) Morpholinderivate und deren verwendung.
DE3671426D1 (de) Dipropargyloxybenzolverbindungen und deren herstellung.
DE3766441D1 (de) Anilinotriazine und deren verwendung.
DE58901101D1 (de) Heterocyclen auf piperazinopiperazinbasis und deren verwendung.
DE3875877D1 (de) Phthalocyaninverbindungen und ihre verwendung.
DE3878349D1 (de) Substituierte acridin-derivate und deren verwendung.
DE3868608D1 (de) Organozinn-alkoxycarbonylphenylmercaptide und deren verwendung.
DE58905492D1 (de) Formmasse und deren Verwendung.
DE3889336D1 (de) Alkyltetramethylcyclohexan-derivate und deren verwendung als duftstoffe.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee